NO980529L - 1- 2-(2,3-dihydro-1H-inden-1-yl)etyl -4-(naftalen-1-yl)piperazinderivater, fremstilling derav og terapautisk anvendelse derav - Google Patents

1- 2-(2,3-dihydro-1H-inden-1-yl)etyl -4-(naftalen-1-yl)piperazinderivater, fremstilling derav og terapautisk anvendelse derav

Info

Publication number
NO980529L
NO980529L NO980529A NO980529A NO980529L NO 980529 L NO980529 L NO 980529L NO 980529 A NO980529 A NO 980529A NO 980529 A NO980529 A NO 980529A NO 980529 L NO980529 L NO 980529L
Authority
NO
Norway
Prior art keywords
therapeutic use
inden
naphthalen
dihydro
ethyl
Prior art date
Application number
NO980529A
Other languages
English (en)
Other versions
NO980529D0 (no
Inventor
Pascal George
Mireille Sevrin
Philippe Manoury
Michel Peynot
Daniele De Peretti
Jean Francois Gibert
Arlette Tixidre
David Machnik
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO980529D0 publication Critical patent/NO980529D0/no
Publication of NO980529L publication Critical patent/NO980529L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Forbindelser med generell formel (I) hvor X er et hydrogen- atom, en hydroksygruppe, en C-i-C3 alkoksygruppe eller en cyklopropylmetoksygruppe og Y er et hydrogenatom, en hydroksygruppe eller en metoksygruppe, for terapeutisk bruk.
NO980529A 1995-08-09 1998-02-06 1- 2-(2,3-dihydro-1H-inden-1-yl)etyl -4-(naftalen-1-yl)piperazinderivater, fremstilling derav og terapautisk anvendelse derav NO980529L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509684A FR2737724B1 (fr) 1995-08-09 1995-08-09 Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4- (naphtalen-1-yl) piperazine, leur preparation et leur application en therapeutique
PCT/FR1996/001216 WO1997006155A1 (fr) 1995-08-09 1996-08-01 Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NO980529D0 NO980529D0 (no) 1998-02-06
NO980529L true NO980529L (no) 1998-04-14

Family

ID=9481836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980529A NO980529L (no) 1995-08-09 1998-02-06 1- 2-(2,3-dihydro-1H-inden-1-yl)etyl -4-(naftalen-1-yl)piperazinderivater, fremstilling derav og terapautisk anvendelse derav

Country Status (20)

Country Link
US (1) US5929078A (no)
EP (1) EP0843670A1 (no)
JP (1) JP2000501699A (no)
KR (1) KR19990035954A (no)
CN (1) CN1199398A (no)
AR (1) AR003222A1 (no)
AU (1) AU707372B2 (no)
BR (1) BR9609977A (no)
CA (1) CA2228843A1 (no)
CO (1) CO4750833A1 (no)
CZ (1) CZ36898A3 (no)
FR (1) FR2737724B1 (no)
HU (1) HUP9802546A3 (no)
IL (1) IL123187A0 (no)
NO (1) NO980529L (no)
NZ (1) NZ315363A (no)
PL (1) PL324966A1 (no)
SK (1) SK16798A3 (no)
WO (1) WO1997006155A1 (no)
ZA (1) ZA966772B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242011B (en) 1997-03-31 2005-10-21 Eisai Co Ltd 1,4-substituted cyclic amine derivatives
US8106074B2 (en) 2001-07-13 2012-01-31 Pierre Fabre Medicament Pyridin-2-yl-methylamine derivatives for treating opiate dependence

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE358300A (no) * 1928-04-28
US2927924A (en) * 1958-04-03 1960-03-08 Lilly Co Eli Novel phenethyl-substituted piperazines
NL132357C (no) * 1966-09-03
DE2037852C3 (de) * 1970-07-30 1980-06-26 Boehringer Sohn Ingelheim Neue Piperazinderivate und Verfahren zu ihrer Herstellung
AU684874B2 (en) * 1993-12-28 1998-01-08 Pharmacia & Upjohn Company Heterocyclic compounds for the treatment of cns and cardiovascular disorders
FR2716193B1 (fr) * 1994-02-16 1996-04-05 Synthelabo Dérivés de 1[2-(1h-inden-3-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur préparation et leur application en thérapeutique.

Also Published As

Publication number Publication date
NO980529D0 (no) 1998-02-06
AR003222A1 (es) 1998-07-08
PL324966A1 (en) 1998-06-22
WO1997006155A1 (fr) 1997-02-20
HUP9802546A3 (en) 1999-10-28
AU6705396A (en) 1997-03-05
EP0843670A1 (fr) 1998-05-27
KR19990035954A (ko) 1999-05-25
FR2737724B1 (fr) 1997-09-05
MX9801057A (es) 1998-05-31
JP2000501699A (ja) 2000-02-15
ZA966772B (en) 1997-02-19
AU707372B2 (en) 1999-07-08
BR9609977A (pt) 1999-01-12
FR2737724A1 (fr) 1997-02-14
US5929078A (en) 1999-07-27
HUP9802546A2 (hu) 1999-02-01
CA2228843A1 (en) 1997-02-20
SK16798A3 (en) 1998-08-05
IL123187A0 (en) 1998-09-24
NZ315363A (en) 1998-10-28
CO4750833A1 (es) 1999-03-31
CZ36898A3 (cs) 1998-05-13
CN1199398A (zh) 1998-11-18

Similar Documents

Publication Publication Date Title
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
YU32100A (sh) Derivati hidrosamske kiseline kao inhibitori matrične metaloproteaze (mmp)
NO963053L (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
ES2038622T3 (es) Utilizacion de un derivado de naftaleno y su procedimiento de preparacion.
SE8503922L (sv) Analgetiska 1,2-bensisotiazol-3-ylpiperazin-derivat
ES2147399T3 (es) Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica.
NO924964D0 (no) Tiazolidinforbindelser og fremgangsmaate til fremstilling derav
DK0508740T3 (da) Thiazolidindionderivater, deres fremstilling og anvendelse.
FI925848A0 (fi) Tizolidinfoereningar, som innehaoller en kinogrupp, deras framstaellning och terapeutiska anvaendningar
NO980529L (no) 1- 2-(2,3-dihydro-1H-inden-1-yl)etyl -4-(naftalen-1-yl)piperazinderivater, fremstilling derav og terapautisk anvendelse derav
ES8800122A1 (es) Un procedimiento para la preparacion de derivados de indeno y naftaleno.
AU2713897A (en) Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
FR2726271B1 (fr) Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole
ES8802515A1 (es) Procedimiento para preparar derivados de (dihidro-4,5-1h-imidazolil-2)-dihidro-2,3-indol
NO991581L (no) N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler
NO954538D0 (no) N-p-halobenzoylmetylderivater av 4-(p-fluorfenyl)-3-((3,4-metylendioksy)fenoksy)metyl)piperidin
NO976024L (no) Anvendelse av N-cykloheksylbenzamider for å behandle tarmlidelser
TR199801683A2 (xx) Yeni �re t�revleri.
UA66759C2 (en) Polyhydroxyphenol derivatives, medicinal compositions and a method for prevention and treatment of bone and cartilage diseases
DE60008890D1 (de) Herstellung von amimide abgeleitet von 6-hydroxy-2,5,7,8-tetramethylchroman-2-säure
ATE64095T1 (de) Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.
NO913429L (no) Fremgangsmaate for fremstilling av 5-benzyl-substituerte benzimidazolin-2-tion-derivater.
NO940984L (no) Benzen-derivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application